Day :
Keynote Forum
Marsha Luginbuehl
ChildUplift.Inc, USA
Keynote: Wake Up America! Impact of sleep disorders on school performance
Time : 10:00-10:25
Biography:
Dr. Marsha Luginbuehl, Ph.D., NCSP is a nationally certified school psychologist, CEO of Child Uplift, Inc., and author/publisher of the Sleep Disorders Inventory for Students (SDIS). Dr. Luginbuehl received the American Psychological Association’s “2003 Outstanding Dissertation of the Year Award” for her interdisciplinary collaboration with pediatric health experts to develop the SDIS. Her scientific publications promote the universal screening of specific high risk groups of children whose unidentified sleep disorders impair cognition, learning, behaviors and/or long-term health. Luginbuehl promotes early screening, identification and treatment of pediatric sleep disorders to improve school performance, quality of life and long-term productivity for children.
Abstract:
Many pediatric professionals are unaware of the fact that one out of every three elementary school-aged children has a significant sleep problem/disorder and the most frequently asked questions to pediatricians are concerns about their child’s sleep problems (Mindell & Owens, 2003). This question is most commonly answered by pediatricians incorrectly when they tell the parent to be patient and their toddler/child will eventually grow out of it. This is not true for about 20% of all pediatric sleep problems/disorders. Although some of these sleep problems/disorders do resolve themselves without treatment or interventions, approximately 17% of students in the United States have a serious sleep disorder needing treatment that negatively impacts their educational success (Ax, 2006; National Institute of Health, 2001). This prevalence rate is approximately 2.5 to 3 times higher in students than vision and hearing problems combined, but most pediatricians and school professionals are not doing sleep screenings due to lack of knowledge about quick and accurate screening methods. Consequently, only about 1-2% of these students with sleep disorders are screened, identified, and receive appropriate interventions or treatment (Rosen,2001). The average time that elapses from onset of a sleep disorder until diagnosis is at least 10 to 15 years (Rosen, 2001). Recent research suggests that ~30% of children with correctable sleep disorders are initially diagnosed with learning disabilities, cognitive delays, and/or behavioral and emotional disorders, including ADHD (French, 2008; Luginbuehl, 2004; Popkave, 2007; Witte, 2007). However, when the sleep disorder is finally identified and corrected, the student’s academic progress often improves and behavior/emotional problems decrease (many studies). School psychologists can significantly improve the academic and behavioral performance of students and reduce their schools remediation and behavioral intervention expenditures by using a simple sleep screening process to identify and correct students sleep problems.
Goals and Objectives: Participants will learn about the six most common sleep disorders, how to identify, diagnose, and treat them, and understand their negative educational impact if not corrected early. Early correction will reduce academic delays, behavior problems, school district and healthcare expenditures for academic remediation and special education services while improving long-term health, employment success, and quality of life.
Purpose and Content: The purpose of this presentation is to provide participants with knowledge and skills related to the definition and impact of pediatric sleep disorders, as well as develop an effective screening and identification process at pediatric practices, Child Find and school screenings to identify the six primary sleep disorders impacting children and youth. Specifically, the definition of the six major pediatric sleep disorders will be discussed: Obstructive Sleep Apnea, Narcolepsy, Periodic Limb Movement Disorder, Restless Legs Syndrome, Behavioral Insomnia of Childhood, and Delayed Sleep Phase Syndrome. Research demonstrating the high prevalence of these sleep disorders, as well as the negative impact of each on student brain functioning/cognition, achievement, attention span, activity level, behavioral/emotional development when these sleep problems/disorders go unidentified and untreated. Untreated sleep disorders also cause serious long-term health problems and vehicular/work place accidents and could be presented if given enough time (1 ½ - 4 hrs.). Screening of sleep disorders will be presented in the context of the healthcare model of early identification and intervention. Although there are over 183 pediatric sleep screening instruments available worldwide, only one screening instrument, the Sleep Disorders Inventory for Students (SDIS), screens for all the major pediatric sleep disorders, has quick computer scoring that produces a comprehensive report for pediatricians and parents, and has used all 11-recommended validation steps of instrument development (Spruyts & Gozal, 2011). The SDIS won the 2003 Dissertation of the Year Award from the American Psychological Association for its extensive collaboration with pediatric sleep specialists, pediatricians, psychologists, and measurement experts to produce an effective screening instrument with highly valid and reliable psychometric properties. The emphasis of this presentation is on identifying and resolving sleep problems/disorders with early screening and treatment before they significantly impair students’ achievement and behavioral/emotional regulation or cause later health problems or accidents. Discussion of interventions for the six major pediatric sleep disorders will include medical interventions including surgery or medications used to treat four of the sleep disorders, and behavioral interventions that can be used in the school and home settings for two of the behavioral sleep disorders. Finally, time will be allotted at the end for questions and answers.
Keynote Forum
Howard S Weber
Penn State Hershey Childrens Hospital, USA
Keynote: Correction of congenital heart disease in the current era: From the operative room to the catheterization lab
Time : 09:35-10:05
Biography:
Howard S. Weber completed his fellowship in Pediatric Cardiology at Yale New Haven Hospital in 1989 and immediately began his career as an assistant professor of pediatrics at the Penn State Hershey Childrens Hospital and also director of the catheterization lab. He has published more than 50 articles in various national and international peer reviewed cardiology journals and serves on numerous editorial boards of these same journals. He has been an invited lecturer at numerous interventional pediatric cardiology meetings both nationally and internationally.
Abstract:
Since the introduction of the first interventional pediatric catheterization technique of balloon pulmonary valvuloplasty in the early 1980’s, the field of interventional pediatric cardiology has expanded exponentially. Cardiac catheterization for congenital heart disease prior to the 1980’s was utilized entirely for diagnostic purposes which currently has been replaced by non-invasive imaging modalities such as two dimensional echocardiography, magnetic resonance imaging and ultrafast CT scanning. As a result, many patients with congenital heart disease do not require a diagnostic cardiac catheterization prior to surgical repair. In contrast, the majority of cardiac catheterization procedures performed in children and adults with structural congenital heart disease today are for therapeutic purposes. This lecture will focus on the current strategies and therapies that have been developed over the past thirty years for the treatment various congenital heart defects which can be corrected in the catheterization lab thereby avoid the need for invasive cardiac surgery and cardiopulmonary bypass. A description of various procedures and results will be presented including several specific techniques that have been developed at the Penn State Hershey Children’s Hospital.
Keynote Forum
Carlos Sánchez Salguero
Port Royal University Hospital, Spain
Keynote: Development of new techniques in specific oral tolerance induction
Time : 10:05-10:35
Biography:
Carlos Sánchez Salguero has completed his PhD at the age of 23 years from Cadiz University and Postdoctoral studies from Cadiz University Hospital and School of Medicine. He is the Director of the Section of Pediatric Allergy and Professor of Pediatrics at the University of Cadiz. He is also President of the Association of Children's Allergy southern Spain and belongs to the Food Allergy Committee of the Spanish Society of Pediatric Allergy.
Abstract:
The food allergy is a multifactorial disorder resulting from the interaction between genetic and environmental factors. Strategies to prevent food allergy by early intervention on pregnant mothers and infants have not been successful and until recently the only tool available for the treatment of food allergy diet has been the avoidance of the food or food to which the patient was allergic. These diets can lead to a psychological and financial burden on children, families and society. It also forces the patient to carry emergency medication to treat allergic reactions that may occur by accidental ingestion or contact with the food. It is clear that the patient is suffering great social constraints and deterioration in their quality of life. Although food allergy, such as milk and eggs, may resolve spontaneously, in some children may persist throughout life. 15% of infants allergic to milk remain allergic after 5 years and 25% of children allergic to egg from 7 years. These patients are usually very sensitive and have severe allergic reactions to accidental exposures. It seems clear that in addition to the problems arising from the implicit exclusion diet foods such as milk, eggs or cereal, natural evolution does not solve allergy in all patients. In recent years efforts have been made in the development of an active treatment option for allergy foods that could benefit especially children with persistent allergy with little possibility of tolerance. They are designed and explore new immunotherapeutic interventions for active treatment of this allergy. Although not investigated, allergen-specific options like Formula Chinese Herbs or Omalizumab (anti-IgE antibody monoclonal); most researchers have used immunotherapy (IT) allergen-specific for the treatment of food allergy.